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Given that few studies have examined the interaction between endocrine-inﬂammatory mediators and
aerobic exercise training in hypertensive postmenopausal women, the aim of this study was to inves-
tigate whether aerobic exercise training (AET) for twenty-four sessions would alter cortisol, leptin and
interleukin-1b (IL-1b) levels. To further analyze endothelium function in response to AET, we also
examined redox state as well as NO/cGMP pathway in this population. Eighteen hypertensive post-
menopausal women ﬁnished this study. AET program consisted of 24 sessions in treadmill, 3 times per
week, duration of 30 up to 40 min for each session, for 8 weeks at intensity of 100% of the MLSS ac-
cording to previous incremental test. Heart rate was monitored in all studied time (resting and during
exercise sessions). After 48 h of the last exercise session, blood samples were collected for biochemical
analyses (levels of cortisol, leptin, IL-1b, nitrite/nitrate (NOx), cGMP, malondialdehyde (MDA) and
asymmetric dimethylarginine (ADMA); superoxide and catalase activity). We also measured systolic and
diastolic blood pressure. A signiﬁcant reduction in body mass was observed. As expected, systolic and
diastolic blood pressure values were signiﬁcantly reduced after AET in hypertensive women. We also
found a marked increase in NOx levels as well as cGMP concentration in trained women, approximately
37.7 and 30.8%, respectively. No changes in cortisol, leptin, ADMA and IL-1b levels were observed after
AET. Similarly, MDA levels and catalase activity were not affected by AET. In contrast, a marked increase
in SOD activity was found (86.6%). In conclusion, our ﬁndings show that aerobic exercise training for
twenty-four sessions promoted a signiﬁcant reduction in blood pressure by activating NO/cGMP pathway
as well as by promoting an up-regulation of SOD activity without changing in cortisol/leptin levels in
postmenopausal hypertensive women.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Epidemiological studies have shown that the incidence of car-
diovascular diseases (CVD) in women increases dramatically after
menopause [1,2]. However, the underlying mechanisms are not yet
fully clariﬁed. Several hypotheses have been proposed to explain thisBY-NC-ND license (http://
of interest.
Paulo Research Foundation
oamento de Pessoal de Nível
: þ55 19 3526 4321.
otmail.com (A. Zanesco).
Published by Elsevier Inc. All rightphenomenon in postmenopausal women. Estrogen deﬁciency has
been pointed out to play a major role, but its deﬁciency partially
explains the increased incidence of CVD since hormone replacement
therapy did not prevent or mitigated cardiovascular events in this
population [3,4]. Oxidative stress is another explanation, where
increased production of the inﬂammatory mediators would lead to a
massive production of reactive oxygen species, which in turn,
resulting in endothelium dysfunction with decrease in nitric oxide
(NO) production or its bioavailability to the cells [5]. However, some
studies found a positive association between CVD and inﬂammatory
mediators [6e8] whereas others failed to detect any association [9]
in climacteric phase. The hypothalamic-pituitary-adrenal axis has
also been linked to the higher incidence of CVD in postmenopausal
women [10,11]. Nevertheless, the number of studies examining the
interaction between menopause status and glucocorticoids is scarce.s reserved.
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still a complex issue and further studies should be carried out to look
at the insight mechanisms as well as to get more information in an
attempt to prevent cardiovascular events in this population. On the
other hand, a plethora of studies has shown that physically active
subjects have more longevity with reduction of morbidity and
mortality [12,13]. Given that few studies have examined the inter-
action between endocrine-inﬂammatory mediators and aerobic ex-
ercise training in hypertensive postmenopausal women, the aim of
this study was to investigate whether aerobic exercise training for
twenty-four sessions would alter cortisol, leptin and interleukin-1b
levels. To further analyze endothelium function in response to ex-
ercise training, we also examined redox state as well as NO/cGMP
pathway in this population.Methodology
Study participants
This study was approved by the Ethical Committee of Institute of
Bioscience at the University of São Paulo State (UNESP). All the vol-
unteers were recruited through advertisements in the surrounding
area of UNESP. A total of thirty-two volunteers were eligible to
participate in the study. After all screening test, only eighteenwomen
ﬁnished the study. Postmenopausal status was determined as the
absence of menstruation for at least 1 year under natural or surgical
causes were classiﬁed as hypertensive according to previous medical
diagnosis (systolic blood pressure: 140e159 mm Hg, diastolic blood
pressure: 90e99 mm Hg or using anti-hypertensive). The inclusion
criteria of this study were: to be hypertensive; body mass index
30 kg/m2; sedentary (<150 min of moderate physical activity per
week or <60 min of vigorous physical activity per week). The
exclusion criteria were: smoking, taking hormone replacement
therapy, diabetic, cardiovascular disease (stroke, heart failure); renal
dysfunction; other condition that precludes the practice of physical
exercise. Before starting the protocol, volunteers were informed
about the procedures and risks of the study and signed a consent
form in accordance with Ethical Committee of UNESP.Study protocol
This clinical trial lasted 10 weeks and all parameters were
evaluated at initial time and after 24 sessions of the aerobic ex-
ercise training (AET). Initially, the anthropometric and cardio-
vascular parameters were measured and volunteers were
familiarized to the treadmill during 2e4 days, depending uponFigure 1. Experimeach participant. After familiarization, maximal lactate steady
state (MLSS) was deﬁned individually for prescription of AET in-
tensity. Brieﬂy, postmenopausal women performed two to ﬁve
tests with ﬁxed duration (30 min) and walking speed (5.5 km/h)
on a treadmill (Movement RT 250 PRO) in accordance with pre-
vious study [14]. The inclination of the ergometer was used to
control the intensity that ranged between 1 and 15%. The intensity
was adjusted in each test according to the aerobic capacity of the
participant. Measurement blood lactate concentration was per-
formed at rest, 10th and 30th min during incremental test. MLSS
was determined when the difference of blood lactate concentra-
tion between 10th and 30th min was not exceeded 1 mM [15].
AET program consisted of 24 sessions in treadmill, 3 times per
week, duration of 30 up to 40 min for each session, for 8 weeks. The
intensity of the AET was 100% of the MLSS according to previous
incremental test. Heart ratewas monitored and AETwas supervised
by exercise physiologists in an environmental with temperature
(z25 C) and humidity (40e60%) controlled. Figure 1 illustrates the
experimental design.
Anthropometric parameters
Body weight and height was determined using a scale and sta-
diometer (Toledo 2096 PP). Body mass index was calculated as the
ratio body weight divided by the square of the height in meters.
Waist circumference was measured at the midpoint between the
last rib and iliac crest.
Cardiovascular parameters
Blood pressure (BP) e After 20 min of sitting position, three
consecutives BP measurements using a semi-automatic equipment
(Microlife MIB-P3BTOA). Resting BP was determined as the average
of the measurements.
Heart rate (HR) e HR was measured using a heart rate monitor
(Polar FT1 TRQ) after 20 min of seated position. At the ﬁnal of the
resting period the value of HR was obtained.
Blood samples
Blood samples were collected after 12 h of overnight fast
(between 7:00 and 8:00 am). Blood samples were collected from
the antecubital vein using standard venipuncture methods.
Samples were centrifuged (3000 rpm, 12 min) and the superna-
tant (plasma and serum) were stored in aliquots at 80 C for
future analysis.ental design.
Table 1
Effects of aerobic exercise training on anthropometrical parameters, lipid proﬁle,
glycemia and MLSS in hypertensive postmenopausal women.
Parameters (n ¼ 18) Initial Final
Age (yrs) 58.3  1.2 e
Time after menopause (yrs) 10.3  2.1 e
BMI 27.3  0.5 26.9  0.5*
WC 94.4  1.6 93.4  1.5*
TC (mg/dL) 195.4  6.4 194.1  5.5
LDL-c (mg/dL) 124.7  6.4 124.2  5.0
HDL-c (mg/dL) 46.9  1.7 49.1  1.5
VLDL-c (mg/dL) 23.8  1.9 20.6  1.5
TG (mg/dL) 113.8  10 103.1  7.8
Glycemia (mg/dL) 87.2  2.2 90.3  2.1
Rest HR 67.3  2.7 64.7  2.2*
MLSS exercise HR 152  4.7 151  5.1
MLSS threshold 5.5  0.4 7.3  0.5*
BMI ¼ body mass index (kg/m2); WC ¼ waist circumference (cm); TC ¼ total
cholesterol; LDL ¼ low density lipoprotein; HDL ¼ high-density lipoprotein;
VLDL ¼ very low-density lipoprotein; TG ¼ triglycerides. HR ¼ heart rate (bpm);
MLSS ¼ maximal lactate steady state; Data are mean  SEM.
*P < 0.05 compared with initial time.
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Lipid proﬁle and glycemia e Serum concentrations of total
cholesterol, low-density lipoprotein-cholesterol, very low-density
lipoprotein cholesterol, high-density lipoprotein cholesterol, tri-
glycerides and glycemia were determined using automated standard
method (Cobas Mira Plus).
Cortisol e Serum concentrations of cortisol were measured by
the chemiluminescence (ADVIA Centaur). This is a competitive
immunoassay that uses direct chemiluminescent technology.
Leptin e Serum leptin concentrations were measured by ELISA
using a commercial available kit (SPI Bio, Montigny-le-Bretonneux,
France) according to the manufacturer’s instructions.
Interleukin-1b (IL-1b) and guanosine cyclic monophosphate
(cGMP)e Plasma concentrations of IL-1b and cGMP were measured
by ELISA using a commercial available kit (R&D Systems, Mine-
apolis, MN, USA) according to the manufacturer’s instructions.
Asymmetric dimethylarginine (ADMA) e Plasma concentrations of
ADMA were measured by ELISA using a commercial available kit
(Immunodiagnostik AG, Bensheim, Germany) according to the man-
ufacturer’s instructions.
Nitrite/Nitrate (NOx
) e Plasma concentrations of NOx were
measured to evaluate NO production by commercial available kit
(Cayman Chemical, Ann Arbor, MI, USA) according to the manufac-
turer’s instructions. Before starting this assay samples were ultra-
ﬁltered through micro ﬁlter (Microcon Centrifugal Filter Units,
10 kDa, Millipore, Bedford, MA).
Superoxide dismutase (SOD), catalase andmalondialdehyde (MDA)e
All these markers were measured by ELISA using a commercial avail-
able kit (Cayman Chemical, Ann Arbor, MI, USA) according to the
manufacturer’s instructions. SOD’s assay detects radicals superoxide
generated by xanthine oxidase and hypoxanthine, revealing the plas-
matic activity of this enzyme. Catalase’s assay is based on the reaction
of theenzymewithmethanol inanoptimalH2O2concentration. Serum
levels of MDAwere determined to evaluate lipid peroxidation [16].Figure 2. Effects of aerobic exercise training on systolic blood pressure (SBP, panel A),
diastolic blood pressure (DBP, panel B) and resting heart rate (HR, panel C) in post-
menopausal hypertensive women (n ¼ 18). *P < 0.05 paired t test between initial and
ﬁnal time of the study.Statistical analysis
Data are presented asmean standard errormean. Normality of
the data was veriﬁed by the KolmogoroveSmirnov’s test. A paired
Student’s t-test was used to analyze the effect of AET on the car-
diometabolic and endocrine parameters. For all analyses, P < 0.05
was considered statistically signiﬁcant.Results
Body mass index values were signiﬁcantly reduced in hyperten-
sive postmenopausal women after 24 sessions of AET approximately
1.5% as compared to initial time. However, no changes were found in
waist circumference, lipid proﬁle and glycemia. On the other hand,
the intensity of physical exercise employed in our study was effective
to promote a signiﬁcant increase in MLSS after AET, approximately
32.7%. Data are summarized in Table 1. Regarding antihypertensive
therapy, 67% of the participants were on renin-angiotensin inhibitors
or AT1 receptor blockers whereas six volunteers were on diuretics or
beta-adrenergic receptor blocker therapy (33%). Regarding hypo-
lipidemic compound, 50% of the volunteers were on therapy previ-
ously to the study.
As expected, AET was effective in lowering arterial blood pres-
sure in trained HT women, approximately 3.8% and 5.9% for
systolic and diastolic blood pressure, respectively (Figure 2, panels
A and B). Resting heart rate values were also decreased after 24
Figure 3. Effects of aerobic exercise training on NOx (panel A), cGMP (panel B) and
ADMA (panel C) levels in postmenopausal hypertensive women (n ¼ 18). *P < 0.05
paired t test between initial and ﬁnal time of the study.
Figure 4. Effects of aerobic exercise training on SOD (panel A), catalase (panel B) ac-
tivity and MDA concentration (panel C) in postmenopausal hypertensive women
(n ¼ 18). *P < 0.05 paired t test between initial and ﬁnal time of the study.
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that it is well established that the health beneﬁcial effect of the ex-
ercise training is related to activation of NO/cGMP signaling pathway,
we have evaluated these biomarkers before and after twenty-four
sessions of aerobic physical exercise. We found a marked increase
in NOx levels, which reﬂect NO production, as well as cGMP con-
centration in trained women, approximately 37.7 and 30.8%,
respectively (Figure 3, panels A and B). Interestingly, we found no
changes in ADMA levels (Figure 3C).
Furthermore, we also analyzed the redox state by measuring SOD
and catalase activities and MDA concentration. Our ﬁndings show
that AET promoted a profound increase in SOD activity, approxi-
mately 86.6% (Figure 4A). No changes were found catalase activity
and MDA concentration (Figure 4, panels B and C).
Regarding endocrine-inﬂammatory mediators, we found no ef-
fects of the AETon cortisol, leptin and IL-1b levels in postmenopausal
hypertensive women (Figure 5, panels A, B and C, respectively).
Interestingly, we found a positive relationship between systolic bloodpressure values and cortisol levels at initial time of the study
(r2 ¼ 0.2422, P < 0.0448, n ¼ 17, Figure 6A) whereas this correlation
was abrogated after AET (P > 0.05, Figure 6B).
Discussion
Anumber of studies have shown that cardiovascular diseases can
be prevented by regular physical exercise either in human or in
laboratory animals, which is strongly associated with an increase in
NO bioavailability [17e19]. Regarding postmenopausal women,
recent study found that aerobic exercise training even in a low in-
tensity promoted reductions in blood pressure showing how
changing in the lifestyle is favorable for this particular population in
preventing cardiovascular events [20]. However, no mechanist
Figure 5. Effects of aerobic exercise training on cortisol (panel A), leptin (panel B) and
IL-1b levels (panel C) in postmenopausal hypertensive women (n ¼ 18). *P < 0.05
paired t test between initial and ﬁnal time of the study.
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to examine different pathways that regulate blood pressure in
response to exercise training in hypertensive postmenopausal
women. We found that twenty-four sessions of aerobic physical
exercise was effective in reducing BMI as well as to improve the
physical capacity of all volunteers. Additionally, the reductions of
systolic and diastolic blood pressurewere positively associatedwith
an improvementof NO/cGMPpathwayaswell as an up-regulation of
SOD activity. Taken together, these ﬁndings show that aerobic ex-
ercise training promoted an improvement of endothelium function
in hypertensive postmenopausal women. Indeed, previous studies
from our group have systematically demonstrated the beneﬁcial
effects of the exercise trainingon cardiovascular systemby increased
production of NO and/or its bioavailability in postmenopausal
women [21e24]. To further examine the association between NOinhibition and hypertension in postmenopausal women, we looked
at ADMA levels since evidences have linked increased ADMA levels
in patients with angina, arterial hypertension and immune
dysfunctionmainly in elderly andpostmenopausalwomen [25e27].
We found no changes in ADMA levels in trained women excluding
the contribution of this endothelial pathwayon the beneﬁcial effects
of exercise training in blood pressure regulation. In contrast, two
recent studies from the same group showed a decrease in plasma
ADMA in healthy postmenopausal women in response to aerobic
exercise training as well as an inverse relationship between aerobic
ﬁtness and levels of ADMA [28,29]. However, these studies did not
measure NO production, and blood pressure values were not
modiﬁed by exercise training. Thus, more studies should be carried
out to check the contribution of the endogenous inhibition of NO
availability on arterial hypertension as well as the effects of exercise
training on ADMA/NOS pathway.
Increased oxidative stress has been pointed out to play an
important in the pathogenesis of arterial hypertension in men [30]
as well as in postmenopausal women [5,31]. Although evidences
have demonstrated that trained [32] or physically active healthy
postmenopausal women [33] showed a decreased in circulating
concentrations of MDA as compared to sedentary one, no blood
pressure measurements were performed in these studies. Thus, the
data do not clarify the high incidence of arterial hypertension in
postmenopausal women or explain the insight mechanisms in the
phenomenon. In our study, we found no changes in MDA levels in
response to exercise training in hypertensive postmenopausal
women excluding the contribution of this biomarker in the bene-
ﬁcial effects of physical exercise on blood pressure regulation. We
also found no changes in the pro-inﬂammatory mediators, IL-1b
and leptin, in response to exercise training. It has been reported the
inﬂuence of estrogen on pro- and anti-inﬂammatory pathway in
different cells types [34]. Indeed, in whole human blood cultures,
the addition of different concentration of estrogen decreases
secretion of several pro-inﬂammatory mediators, mainly IL-1b [35].
Additionally, it has been demonstrated an increase in inﬂammatory
mediators in experimental model of menopause [36]. Interestingly,
a previous study showed that IL-1b levels increase in the early stage
of the menopause (less than ﬁve years) and return to the normal
levels in the late stage, with values similar to premenopause phase
[8]. Thus, it is not clear whether estrogen deﬁciency could lead to an
inﬂammatory state in postmenopausal women. Furthermore, the
range of concentration of IL-1b levels in women is very wide
varying between 0.30 and 0.081 pg/mL depending on the repro-
ductive phase or not as well as the time after menopause [37].
Regarding leptin levels and postmenopausal women, the interac-
tion is even more complex [38]. An increase [39], no variation [40]
and a decrease [41,42] in circulating leptin levels were detected
after menopause. Previous studies reported that postmenopausal
women under caloric restriction [43] or on tibolone therapy [42]
showed a signiﬁcant reduction in leptin levels. In our study, exer-
cise training did not affect leptin levels even though there was a
slight reduction in the BMI (1.5%). Indeed, previous studies have
shown that changes in leptin levels are detected onlywhen physical
training is associated with caloric restriction in postmenopausal
women [44,45].
A number of studies have shown the importance of cortisol, the
major glucocorticoid hormone produced in human, in elevating
blood pressure [46e48]. Several signaling pathways seem to be
involved in the mechanisms by which cortisol produces arterial hy-
pertension including sodium/volume homeostasis, activation of the
renin-angiotensin system, and increased sympathetic drive [49e52].
Additionally, it has been reported that cortisol impairs NO production
measured by NOx levels attributing thus, the cortisol-induced hy-
pertension to the NO deﬁciency in both human and experimental
r 2 = 0.242
P = 0.044
r 2 = 0.007
P = 0.741
A B
Figure 6. Correlation between systolic blood pressure values and cortisol levels at initial time (panel A) and after twenty-four sessions (panel B) of physical exercise in post-
menopausal hypertensive women.
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interaction between cortisol and arterial hypertension in male sub-
jects [55] and no one examined the effects of exercise training on
endocrine-inﬂammatory mediators in hypertensive postmenopausal
women. In our study, we found no effects of the exercise training in
the cortisol concentration in hypertensive postmenopausal women.
Thus, it is clear that the beneﬁcial effects of exercise training on blood
pressure were related to an improvement of NO/cGMP pathway
without changing in serum cortisol levels. This is conﬁrmed by the
lack of positive correlation between cortisol and blood pressure after
twenty-four sessions of exercise. Collectively, our ﬁndings show that
the endocrine-inﬂammatory mediators: cortisol, leptin and IL-1b did
not contribute to the beneﬁcial effects of the exercise training on
blood pressure in hypertensive postmenopausal women. Further-
more, our study conﬁrms that aerobic exercise training for twenty-
four sessions promoted a reduction in blood pressure by activating
NO/cGMP pathway as well as by promoting an up-regulation of SOD
in this particular population.References
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